3 ms·
Yeah, I saw that one. But the cohort of patients it's talking about already have autoimmune issues and the focus is on the adjunctives. I think there was anoth
by giantg2 5y ago
Yeah, I saw that one. But the cohort of patients it's talking about already have autoimmune issues and the focus is on the adjunctives.
I think there was another one talking about 50% of severe covid patients developing autoimmune antibodies, but with no idea if they will progress to a condition.
I was hoping to see some longterm studies from prior mRNA research. But it's my understanding that the longer research wasn't about inducing immune response but for trying to modify DNA to correct genetic conditions (which failed, but now crispr...).
- kasperset 5y agoI found few case studies for blood clotting which could be due to autoimmune origin. However, no formal studies yet that I could find. Maayan, H., Kirgner, I., Gutwein, O., Herzog-Tzarfati, K., Rahimi-Levene, N., Koren-Michowitz, M., & Blickstein, D. (n.d.). Acquired Thrombotic Thrombocytopenic Purpura: A rare disease associated Acquired with BNT162b2 vaccine. Journal of Thrombosis and Haemostasis, n/a(n/a). https://doi.org/10.1111/jth.15420 https://doi.org/10.1111/jth.15420 Yocum, A., & Simon, E. L. (2021). Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination. The American Journal of Emergency Medicine. https://doi.org/10.1016/j.ajem.2021.05.001 https://doi.org/10.1016/j.ajem.2021.05.001